Rhythm Pharmaceuticals, Inc.
RYTM
$59.93
-$0.25-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 64.99% | -3.98% | 1.10% | 30.92% | -170.94% |
| Total Depreciation and Amortization | -5.43% | -8.15% | -12.90% | -11.76% | -11.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.72% | 373.87% | -16.65% | -52.71% | 717.01% |
| Change in Net Operating Assets | -261.47% | 14.58% | 397.91% | 59.34% | -179.45% |
| Cash from Operations | 0.96% | 35.86% | 13.80% | 29.24% | -11.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.43% | -6.55% | 4.36% | -117.77% | 62.34% |
| Cash from Investing | -17.43% | -6.55% | 4.36% | -117.77% | 62.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 428.24% | 743.23% | -88.54% | 311.14% | 476.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -65.83% | -47.94% | -115.02% | 553.83% | -106.00% |
| Cash from Financing | 665.94% | 1,481.84% | -96.59% | 15,248.08% | 3,290.23% |
| Foreign Exchange rate Adjustments | 97.18% | 608.85% | -883.12% | -166.37% | -182.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 360.05% | 1,022.38% | -123.42% | 1,697.11% | 63.80% |